Literature DB >> 6821700

Response to splenectomy in 65 patients with hairy cell leukemia: an evaluation of spleen weight and bone marrow involvement.

H M Golomb, J W Vardiman.   

Abstract

Sixty-five patients with hairy cell leukemia underwent splenectomy; 27 had a complete remission as defined by a return in WBC, RBC, and platelet counts to a defined level, and 38 had a partial remission with a return of only one or two of these parameters to the defined level. The 5-yr actuarial survival for all patients is 68%; for CR patients it is 76%, and for PR patients 62%. The response to splenectomy did not correlate with the spleen weight. Seventeen patients had a postsplenectomy platelet count of less than 200 x 10(9)/liter, and 34 patients had a postsplenectomy platelet count of 200 x 10(9)/liter or greater. A presplenectomy bone core biopsy hairy cell index (HCI) was calculated by multiplying the percent marrow cellularity by the percent of hairy cells in the marrow for 51 patients. The difference in the mean HCI between the two platelet response groups is statistically significant (p less than 0.05). Of the 15 patients with a presplenectomy HCI of 0.7 or greater, 9 (60%) did not have a satisfactory platelet response to splenectomy, whereas of 36 patients with an HCI of 0.7 or less, only 8(22%) did not have a satisfactory platelet response to splenectomy (p less than 0.01). The HCI appears to indicate the significance of underproduction of platelets as a result of marrow replacement by hairy cells.

Entities:  

Mesh:

Year:  1983        PMID: 6821700

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  16 in total

Review 1.  Hairy cell leukemia: update and current therapeutic approach.

Authors:  Latif Salam; Omar Abdel-Wahab
Journal:  Curr Opin Hematol       Date:  2015-07       Impact factor: 3.284

Review 2.  Hairy cell leukemia: clinical features and therapeutic advances.

Authors:  B C Lembersky; H M Golomb
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  My treatment approach to hairy cell leukemia.

Authors:  Rahul R Naik; Alan Saven
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

4.  [Diagnosis and prognosis of hairy cell leukemia].

Authors:  W Hill; G Kettner; R Burkhardt
Journal:  Klin Wochenschr       Date:  1987-07-15

5.  Retrospective Analysis of Hairy Cell Leukemia Patients Treated with Different Modalities as First Line: Real-Life Experience Over 20 years.

Authors:  Fergün Yılmaz; Dilan Atilla; Nagihan Akkaş; Hale Bülbül; Nur Soyer; Derya Demir; Demet Kiper; Aylin Avcı; Filiz Vural; Güray Saydam; Fahri Şahin; Mine Hekimgil; Nazan Özsan; Raika Durusoy; Bahriye Payzın
Journal:  Indian J Hematol Blood Transfus       Date:  2019-05-13       Impact factor: 0.900

6.  Hairy Cell Leukaemia in Oman: Four cases.

Authors:  Arundathi Kurukulasuriya; Asia Al-Rashdi; Muhanna Al-Muslahi
Journal:  Sultan Qaboos Univ Med J       Date:  2008-11

7.  Splenectomy for hematologic disease. The UCLA experience with 306 patients.

Authors:  G Musser; G Lazar; W Hocking; R W Busuttil
Journal:  Ann Surg       Date:  1984-07       Impact factor: 12.969

8.  Splenectomy for thrombocytopenia.

Authors:  S I Schwartz
Journal:  World J Surg       Date:  1985-06       Impact factor: 3.352

Review 9.  The optimal management of hairy cell leukaemia.

Authors:  R Gollard; T C Lee; L D Piro; A Saven
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

Review 10.  Update on the biology and treatment options for hairy cell leukemia.

Authors:  Preetesh Jain; Naveen Pemmaraju; Farhad Ravandi
Journal:  Curr Treat Options Oncol       Date:  2014-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.